BIO-TECHNE Corp Total Assets

• BIO-TECHNE Corp showed a decrease of -5.4% in Total Assets from 2024 to 2025.
• This data is from BIO-TECHNE Corp's annual report (Form 10-K), filed with the SEC on August 22, 2025.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q3 2010: $539.62 million | Q4 2010: $555.61 million | Q1 2011: $582.82 million | Q3 2011: $628.44 million | Q4 2011: $624.25 million | Q1 2012: $684.03 million | Q3 2012: $712.63 million | Q4 2012: $724.57 million | Q1 2013: $760.29 million | Q3 2013: $779.29 million | Q4 2013: $802.17 million | Q1 2014: $830.57 million | Q3 2014: $1.02 billion | Q4 2014: $1.12 billion | Q1 2015: $1.10 billion | Q2 2015: $1.06 billion | Q3 2015: $1.13 billion | Q4 2015: $1.13 billion | Q1 2016: $1.12 billion | Q3 2016: $1.52 billion | Q4 2016: $1.52 billion | Q1 2017: $1.53 billion | Q3 2017: $1.53 billion | Q4 2017: $1.56 billion | Q1 2018: $1.62 billion | Q3 2018: $1.87 billion | Q4 2018: $1.84 billion | Q1 2019: $1.87 billion | Q3 2019: $1.93 billion | Q4 2019: $2.00 billion | Q1 2020: $2.00 billion | Q3 2020: $2.05 billion | Q4 2020: $2.07 billion | Q1 2021: $2.08 billion | Q3 2021: $2.27 billion | Q4 2021: $2.30 billion | Q1 2022: $2.30 billion | Q3 2022: $2.35 billion | Q4 2022: $2.36 billion | Q1 2023: $2.60 billion | Q3 2023: $2.76 billion | Q4 2023: $2.73 billion | Q1 2024: $2.72 billion | Q3 2024: $2.74 billion | Q4 2024: $2.67 billion | Q1 2025: $2.64 billion | Q2 2025: $2.56 billion | Q3 2025: $2.53 billion | Q4 2025: $2.52 billion.
• Over the full 17 years of available data (2009 to 2025), BIO-TECHNE Corp's Total Assets has grown by 441.9%.
• Historical annual values: Fiscal year 2025: $2.56 billion | Fiscal year 2024: $2.70 billion | Fiscal year 2023: $2.64 billion | Fiscal year 2022: $2.29 billion | Fiscal year 2021: $2.26 billion | Fiscal year 2020: $2.03 billion | Fiscal year 2019: $1.88 billion | Fiscal year 2018: $1.59 billion | Fiscal year 2017: $1.56 billion | Fiscal year 2016: $1.13 billion | Fiscal year 2015: $1.06 billion | Fiscal year 2014: $862.49 million | Fiscal year 2013: $778.10 million | Fiscal year 2012: $719.32 million | Fiscal year 2011: $617.67 million | Fiscal year 2010: $518.82 million | Fiscal year 2009: $472.01 million.
• Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: August 9, 2026